Literature DB >> 23580871

The results of the International Consortium on Acute Promyelocytic Leukemia: a 'proof of concept' of networking as a strategy to improve the outcome of treatment of hematological malignancies in developing countries.

Eduardo Magalhães Rego1.   

Abstract

Entities:  

Year:  2013        PMID： 23580871      PMCID： PMC3621622          DOI： 10.5581/1516-8484.20130001

Source DB:  PubMed          Journal:  Rev Bras Hematol Hemoter        ISSN： 1516-8484


× No keyword cloud information.
  11 in total

1.  Patients with high-risk aPl benefit from risk-adapted consolidation therapy.

Authors:  Lisa Hutchinson
Journal:  Nat Rev Clin Oncol       Date:  2010-09       Impact factor: 66.675

2.  Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome.

Authors:  Miguel A Sanz; Pau Montesinos; Chelo Rayón; Alexandra Holowiecka; Javier de la Serna; Gustavo Milone; Elena de Lisa; Salut Brunet; Vicente Rubio; José M Ribera; Concha Rivas; Isabel Krsnik; Juan Bergua; José González; Joaquín Díaz-Mediavilla; Rafael Rojas; Félix Manso; Gert Ossenkoppele; José D González; Bob Lowenberg
Journal:  Blood       Date:  2010-04-14       Impact factor: 22.113

3.  Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid.

Authors:  Jae H Park; Baozhen Qiao; Katherine S Panageas; Maria J Schymura; Joseph G Jurcic; Todd L Rosenblat; Jessica K Altman; Dan Douer; Jacob M Rowe; Martin S Tallman
Journal:  Blood       Date:  2011-06-08       Impact factor: 22.113

4.  Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710.

Authors:  Bayard L Powell; Barry Moser; Wendy Stock; Robert E Gallagher; Cheryl L Willman; Richard M Stone; Jacob M Rowe; Steven Coutre; James H Feusner; John Gregory; Stephen Couban; Frederick R Appelbaum; Martin S Tallman; Richard A Larson
Journal:  Blood       Date:  2010-08-12       Impact factor: 22.113

5.  Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML).

Authors:  B Falini; L Flenghi; M Fagioli; F Lo Coco; I Cordone; D Diverio; L Pasqualucci; A Biondi; D Riganelli; A Orleth; A Liso; M F Martelli; P G Pelicci; S Pileri
Journal:  Blood       Date:  1997-11-15       Impact factor: 22.113

6.  AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance.

Authors:  Giuseppe Avvisati; Francesco Lo-Coco; Francesca Paola Paoloni; Maria Concetta Petti; Daniela Diverio; Marco Vignetti; Roberto Latagliata; Giorgina Specchia; Michele Baccarani; Eros Di Bona; Giuseppe Fioritoni; Filippo Marmont; Alessandro Rambaldi; Francesco Di Raimondo; Maria Grazia Kropp; Giovanni Pizzolo; Enrico M Pogliani; Giuseppe Rossi; Nicola Cantore; Francesco Nobile; Attilio Gabbas; Felicetto Ferrara; Paola Fazi; Sergio Amadori; Franco Mandelli
Journal:  Blood       Date:  2011-03-08       Impact factor: 22.113

7.  Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.

Authors:  S Lehmann; A Ravn; L Carlsson; P Antunovic; S Deneberg; L Möllgård; A Rangert Derolf; D Stockelberg; U Tidefelt; A Wahlin; L Wennström; M Höglund; G Juliusson
Journal:  Leukemia       Date:  2011-04-19       Impact factor: 11.528

Review 8.  Analysis of the molecular genetics of acute promyelocytic leukemia in mouse models.

Authors:  E M Rego; P P Pandolfi
Journal:  Semin Hematol       Date:  2001-01       Impact factor: 3.851

9.  Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL.

Authors:  Eduardo M Rego; Haesook T Kim; Guillermo J Ruiz-Argüelles; Maria Soledad Undurraga; Maria del Rosario Uriarte; Rafael H Jacomo; Homero Gutiérrez-Aguirre; Raul A M Melo; Rosane Bittencourt; Ricardo Pasquini; Katia Pagnano; Evandro M Fagundes; Maria de Lourdes Chauffaille; Carlos S Chiattone; Lem Martinez; Luis A Meillón; David Gómez-Almaguer; Hau C Kwaan; Javier Garcés-Eisele; Robert Gallagher; Charlotte M Niemeyer; Stanley L Schrier; Martin Tallman; David Grimwade; Arnold Ganser; Nancy Berliner; Raul C Ribeiro; Francesco Lo-Coco; Bob Löwenberg; Miguel A Sanz
Journal:  Blood       Date:  2013-01-14       Impact factor: 22.113

10.  Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines.

Authors:  Rafael Henriques Jácomo; Raul Antonio Morais Melo; Fernanda Ribeiro Souto; Ederson Roberto de Mattos; Claudia Teresa de Oliveira; Evandro M Fagundes; Henrique Neves da Silva Bittencourt; Rosane Isabel Bittencourt; Teresa Cristina Bortolheiro; Eduardo J A Paton; Rodrigo Bendlin; Sebastião Ismael; Maria de Lourdes Chauffaille; Dirceu Silva; Katia Borgia B Pagnano; Raul Ribeiro; Eduardo M Rego
Journal:  Haematologica       Date:  2007-10       Impact factor: 9.941
View more
  2 in total

1.  The Guidelines Project: Brazilian guidelines for acute promyelocytic leukemia.

Authors:  Milton Artur Ruiz
Journal:  Rev Bras Hematol Hemoter       Date:  2014

2.  Follow-up and outcome of the twelve-year experience in adult patients with acute promyelocytic leukemia.

Authors:  Giovanna Steffenello-Durigon; Alisson Bigolin; Ana Carolina Rabello de Moraes; Renata Cristina Rudolf-Oliveira; Joanita Angela Gonzaga Del Moral; Maria Claudia Santos-Silva
Journal:  Hematol Transfus Cell Ther       Date:  2020-01-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.